Biodexa Pharmaceuticals Plc (BDRX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 12.42M | 8.99M | 8.81M | 7.52M | 7.03M | 7.26M | 4.69M | 8.69M | 11.76M | 7.03M | 9.28M | 10.27M |
| Cash & Short-Term Investments | 8.52M | 4.04M | 1.67M | 5.05M | 5.97M | 5.23M | 2.84M | 6.42M | 10.06M | 4.2M | 7.55M | 4.33M |
| Cash Only | 8.52M | 4.04M | 1.67M | 5.05M | 5.97M | 5.23M | 2.84M | 6.42M | 10.06M | 4.2M | 7.55M | 4.33M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 221.61K | 4.49M | 715K | 1.92M | 704K | 2.04M | 329K | 1.24M | 33K | 1.4M | 95K | 3.67M |
| Days Sales Outstanding | - | - | - | - | 1.51K | 362.24 | 310.49 | 124.4 | 369.12 | 169.98 | 981.33 | 1.49K |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 462K | 0 | 547K | 0 | 0 | 0 | 1.02M | 0 | 1.42M | 1.38M | 0 |
| Total Non-Current Assets | 5.73M | 5.83M | 5.97M | 6.44M | 3.51M | 698K | 837K | 993K | 1.15M | 1.25M | 542K | 1.73M |
| Property, Plant & Equipment | 90.84K | 187K | 324K | 436K | 571K | 693K | 831K | 993K | 1.15M | 1.25M | 542K | 954K |
| Fixed Asset Turnover | - | - | - | - | 0.13x | 0.39x | 0.25x | 0.44x | 0.15x | 0.45x | 0.23x | 0.11x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 5.64M | 5.64M | 5.65M | 6.01M | 2.94M | 5K | 6K | 0 | 0 | 0 | 0 | 778K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | -698K | -837K | -993K | -1.15M | -1.25M | 0 | -1.73M |
| Total Assets | 18.15M | 14.82M | 14.78M | 13.97M | 10.54M | 7.96M | 5.53M | 9.68M | 12.91M | 8.28M | 9.82M | 12M |
| Asset Turnover | - | - | - | - | 0.01x | 0.04x | 0.03x | 0.04x | 0.02x | 0.04x | 0.02x | 0.01x |
| Asset Growth % | 22.78% | 6.13% | 40.2% | 75.43% | 90.81% | -17.76% | -57.21% | 17% | 31.54% | -31.02% | -68.22% | -57.96% |
| Total Current Liabilities | 6.12M | 2.48M | 5.03M | 3.48M | 5.57M | 2.28M | 1.9M | 1.65M | 1.84M | 3.84M | 2.99M | 7.34M |
| Accounts Payable | 0 | 1.41M | 707K | 1.69M | 314K | 1.75M | 339K | 1.28M | 485K | 2.04M | 337K | 2.79M |
| Days Payables Outstanding | - | 58.12 | 33.66 | 41.75 | 41.94 | 42.44 | 27.38 | 33.37 | 43.54 | 53.91 | 37.33 | 40.18 |
| Short-Term Debt | 60.89K | 501K | 430K | 174K | 0 | 0 | 0 | 0 | 0 | 0 | 107K | 3.19M |
| Deferred Revenue (Current) | 0 | 0 | 1.47M | 0 | 926K | 0 | 197K | 0 | 0 | 0 | 68K | 0 |
| Other Current Liabilities | 6.06M | 564K | 921K | 1.44M | 3.3M | 364K | 583K | 198K | 664K | 1.67M | 1.62M | 1.15M |
| Current Ratio | 2.03x | 3.63x | 1.75x | 2.16x | 1.26x | 3.18x | 2.47x | 5.28x | 6.39x | 1.83x | 3.10x | 1.40x |
| Quick Ratio | 2.03x | 3.63x | 1.75x | 2.16x | 1.26x | 3.18x | 2.47x | 5.28x | 6.39x | 1.83x | 3.10x | 1.40x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 643.87K | 909K | 1.42M | 1.76M | 295K | 379.71K | 463K | 546K | 620K | 682K | 110K | 107K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 118K | 208K | 295K | 380K | 463K | 546K | 620K | 682K | 60K | 107K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 643.87K | 909K | 1.31M | 1.55M | 0 | -294 | 0 | 0 | 0 | 0 | 50K | 0 |
| Total Liabilities | 6.76M | 3.39M | 6.46M | 5.24M | 5.86M | 2.66M | 2.36M | 2.19M | 2.46M | 4.52M | 3.1M | 7.45M |
| Total Debt | 60.89K | 501K | 727K | 382K | 464K | 544K | 624K | 713K | 620K | 812K | 260K | 3.3M |
| Net Debt | -8.46M | -3.53M | -942K | -4.67M | -5.51M | -4.68M | -2.21M | -5.71M | -9.44M | -3.39M | -7.29M | -1.03M |
| Debt / Equity | 0.01x | 0.04x | 0.09x | 0.04x | 0.10x | 0.10x | 0.20x | 0.10x | 0.06x | 0.22x | 0.04x | 0.73x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -226.39x | -40.16x | -134.49x | -69.06x | - | - | - | - | - | - | - | - |
| Total Equity | 11.38M | 11.44M | 8.32M | 8.73M | 4.68M | 5.3M | 3.16M | 7.49M | 10.45M | 3.75M | 6.72M | 4.55M |
| Equity Growth % | 36.81% | 31.04% | 77.9% | 64.68% | 47.94% | -29.26% | -69.75% | 99.65% | 55.58% | -17.48% | -65.65% | -81.63% |
| Book Value per Share | 50.42 | 45.26 | 134.33 | 3521.79 | 155933.33 | 757042.00 | 999999.00 | 999999.00 | 999999.00 | 999999.00 | 999999.00 | - |
| Total Shareholders' Equity | 11.38M | 11.44M | 8.32M | 8.73M | 4.68M | 5.3M | 3.16M | 7.49M | 10.45M | 3.75M | 6.72M | 4.55M |
| Common Stock | 14.07M | 61.56K | 6.69M | 3.63M | 1.19M | 277.97K | 108.34K | 98K | 98K | 63K | 63K | 39K |
| Retained Earnings | -102.62M | -154.13M | -150.42M | -147.88M | -144.77M | -138.97M | -135.34M | -130.76M | -127.8M | -125.55M | -122.43M | -117.73M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.19M | 67.77M | 53M | 61.74M | 53M | 53M | 54.72M | 54.72M | 54.72M | 54.72M | 54.72M | 54.36M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |